Oslo, Norway, 08 August 2025
Vistin Pharma ASA will release its second quarter and YTD 2025 results on Friday
15th of August 2025. Vistin Pharma will host a conference call for all
shareholders and interested parties at the same day at 08:30 CET. There will be
a Q&A session following the management discussion.
The conference call will be held in English.
The second quarter conference call will be available via web and audio through
the following access points:
Webcast:
https://edge.media-server.com/mmc/p/vvot47w4
Telephone conference (online registration):
https://register-conf.media-
server.com/register/BI65266ce5abba480f9cda4180274c996b
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.